Home > Income Statement > BIOCON

BIOCON
Consolidated Net Profit

    Back to Income Statement
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹386 Cr₹1,013 Cr₹1,023 Cr₹463 Cr₹648 Cr

What is the latest Consolidated Net Profit of BIOCON ?

The latest Consolidated Net Profit ratio of BIOCON is ₹386 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹386 Cr
Mar2025₹1,013 Cr
Mar2024₹1,023 Cr
Mar2023₹463 Cr
Mar2022₹648 Cr

How is Consolidated Net Profit of BIOCON Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹386 Cr
-61.95
Mar2025 ₹1,013 Cr
-0.90
Mar2024 ₹1,023 Cr
120.99
Mar2023 ₹463 Cr
-28.64
Mar2022 ₹648 Cr -

Compare Consolidated Net Profit of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹60,445.6 Cr -2.7% -7.6% 4.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,280.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹246,737.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,129.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹108,808.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,170.0 Cr -0.2% 2.5% -3% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-2.7%

-7.6%

4.3%

SENSEX

-2.3%

-6.6%

-12%


You may also like the below Video Courses